Publications by authors named "Runfang Wu"

Claim this Profile
M
MW-19, a dihydropyrazole derivative, induces human triple-negative breast cancer cell apoptosis by targeting apoptosis-related pathways.
Nanting Zou, Runfang Wu, Zhao Wu, Chunfei Zhang, Haohong Zhang

Chem Biol Drug Des· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Jian Pi Shen Shi formula alleviates hyperuricemia and related renal fibrosis in uricase-deficient rats via suppression of the collagen-binding pathway.
Na Yin, Xiaosi Li, Weichao Liu, Yan Qi, Runfang Wu, Zhao Wu

Int J Rheum Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV.
Zhengchao Lv, Qin Li, Zaixiong Feng, Xi Zheng, NaYin, Runfang Wu, Zhao Wu

Int Immunopharmacol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of heterocyclic substituted dihydropyrazoles as potent anticancer agents.
Chuan-Huizi Chen, Yuan Jiang, Runfang Wu, Yanling Tang, Chunping Wan

Bioorg Med Chem Lett· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isolation and synthesis of a new benzylated alkamide from the roots of .
Yan-Qing Ye, Zu-Hong Ma, Qiao-Fen Yang, Yan-Qi Sun, Rui-Qi Zhang, Run-Fang Wu

Nat Prod Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis